AI assistant
Unichem Laboratories Ltd. — Regulatory Filings 2026
Apr 12, 2026
61109_rns_2026-04-12_6bbcc1b4-e987-4b0b-8ea7-81f60ce13a7a.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
==> picture [190 x 43] intentionally omitted <==
12[th] April 2026
National Stock Exchange of India Limited BSE Limited Exchange Plaza, Listing Department Bandra Kurla Complex, P.J. Towers, 1[st] Floor, Bandra (E), Mumbai- 400051 Dalal Street, Fort, Mumbai – 400 001 Symbol: UNICHEMLAB Script Code: 506690
Symbol: UNICHEMLAB
Dear Sir/Madam,
Subject: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Unichem Pharmaceuticals (USA), Inc., a wholly-owned-subsidiary of the company has voluntarily recalled its products distributed in USA as under:
| Product description | Reason for recall |
|---|---|
| Buspirone Hydrochloride Tablets, USP Strength: 5 mg Pack size: 500 count bottles |
Out-of-specification (OOS) assay result identified at the 12-month long-term stability timepoint. |
Unichem has not received any reports of any adverse events related to this recall to date. The Company places the highest priority on ensuring patient safety and maintaining product quality throughout every stage of its manufacturing and supply chain processes.
This is for your information and records.
Thanking you, For UNICHEM LABORATORIES LIMITED
==> picture [203 x 35] intentionally omitted <==
==> picture [48 x 47] intentionally omitted <==
PRADEEP BHANDARI Head – Legal & Company Secretary
==> picture [531 x 62] intentionally omitted <==